Founded in Irvine, California, Axonics, Inc. is a medical technology company dedicated to developing and commercializing innovative, minimally invasive sacral neuromodulation solutions. Their core mission is to provide effective treatments for patients suffering from overactive bladder, fecal incontinence, and urinary retention. Axonics' primary product, Axonics Therapy, aims to help patients regain normal bladder and bowel control, offering a significant improvement in their quality of life. The company serves a global market, addressing the needs of millions who experience these debilitating symptoms.
Notable figures affiliated with Axonics include experienced professionals in the medical device industry and investors who support their vision of transforming patient care. Key achievements for Axonics include the successful design and widespread adoption of their sacral neuromodulation therapy, which has been recognized for its efficacy and minimally invasive approach. The overall impact of Axonics has been substantial, providing life-changing relief to patients worldwide and setting new standards in the treatment of bladder and bowel dysfunctions.
